Across preclinical studies, Epitalon has shown: Telomerase activation and telomere extension: Via TRAP assays and fibroblast lifespan extension beyond the Hayflick limit Epigenetic remodeling: Reversal of chromatin aging, histone modulation, and gene promoter binding Redox homeostasis: Increased antioxidant enzymes (SOD, NQO1, catalase) and reduced ROS, lipid peroxidation, and DNA damage Circadian restoration: Upregulation of AANAT/pCREB, normalized melatonin and cortisol rhythms, and clock gene modulation in humans Cancer risk reduction: Reduced tumor multiplicity and delayed onset in HER-2/neu and colon cancer models
In a summary analysis of multiple trials, it was found that "A lower energy intake was considered the key factor responsible for bodyweight reduction," meaning that a lower calorie intake was the most important factor in weight loss when taking obesity medicine
Patients should confirm whether any modifications to the standard preparation are recommended based on their medication status
Combination protocols remain individualizednot all patients are candidates, and your physician will determine whether dual-compound therapy aligns with your clinical picture and safety profile
Certain drug interactions and metabolic conditions may shift the riskbenefit calculation, making alternative weight loss strategies more appropriate for your specific situation
Consume one capsule dailypreferably with food
